Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans.

Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE Jr, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A.

J Virol. 2017 Oct 4. pii: JVI.01469-17. doi: 10.1128/JVI.01469-17. [Epub ahead of print]

2.

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.

Delgado FG, Torres KI, Castellanos JE, Romero-Sánchez C, Simon-Lorière E, Sakuntabhai A, Roth C.

Viruses. 2018 Sep 7;10(9). pii: E480. doi: 10.3390/v10090480.

3.

Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.

Lim MQ, Kumaran EAP, Tan HC, Lye DC, Leo YS, Ooi EE, MacAry PA, Bertoletti A, Rivino L.

Front Immunol. 2018 Oct 1;9:2225. doi: 10.3389/fimmu.2018.02225. eCollection 2018.

PMID:
30327651
4.

CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Rivino L, Lim MQ.

Immunology. 2017 Feb;150(2):146-154. doi: 10.1111/imm.12681. Epub 2016 Nov 27. Review.

5.

Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.

Herrera BB, Tsai WY, Chang CA, Hamel DJ, Wang WK, Lu Y, Mboup S, Kanki PJ.

J Virol. 2018 Mar 14;92(7). pii: e01992-17. doi: 10.1128/JVI.01992-17. Print 2018 Apr 1.

6.

Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.

Badolato-Corrêa J, Sánchez-Arcila JC, Alves de Souza TM, Santos Barbosa L, Conrado Guerra Nunes P, da Rocha Queiroz Lima M, Gandini M, Bispo de Filippis AM, Venâncio da Cunha R, Leal de Azeredo E, de-Oliveira-Pinto LM.

Immun Inflamm Dis. 2018 Jun;6(2):194-206. doi: 10.1002/iid3.203. Epub 2017 Dec 28.

7.

Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells.

Wen J, Tang WW, Sheets N, Ellison J, Sette A, Kim K, Shresta S.

Nat Microbiol. 2017 Mar 13;2:17036. doi: 10.1038/nmicrobiol.2017.36.

8.

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.

Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7852-7. doi: 10.1073/pnas.1607931113. Epub 2016 Jun 27.

9.

Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.

Roth C, Delgado FG, Simon-Lorière E, Sakuntabhai A.

Int J Environ Res Public Health. 2018 Feb 23;15(2). pii: E385. doi: 10.3390/ijerph15020385. Review.

10.

Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge.

Wen J, Elong Ngono A, Regla-Nava JA, Kim K, Gorman MJ, Diamond MS, Shresta S.

Nat Commun. 2017 Nov 13;8(1):1459. doi: 10.1038/s41467-017-01669-z.

11.

T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.

Herrera BB, Tsai WY, Brites C, Luz E, Pedroso C, Drexler JF, Wang WK, Kanki PJ.

MBio. 2018 Aug 7;9(4). pii: e00755-18. doi: 10.1128/mBio.00755-18.

12.

ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.

Andrade P, Coloma J, Harris E.

Methods Mol Biol. 2018;1808:151-163. doi: 10.1007/978-1-4939-8567-8_13.

PMID:
29956181
13.

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.

Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS.

MBio. 2016 Jul 19;7(4). pii: e01123-16. doi: 10.1128/mBio.01123-16.

14.

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus.

Paquin-Proulx D, Leal FE, Terrassani Silveira CG, Maestri A, Brockmeyer C, Kitchen SM, Cabido VD, Kallas EG, Nixon DF.

Pathog Immun. 2017;2(2):274-292. doi: 10.20411/pai.v2i2.188. Epub 2017 Jun 30.

15.

In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations.

Dos Santos Franco L, Oliveira Vidal P, Amorim JH.

J Biomed Sci. 2017 Nov 23;24(1):88. doi: 10.1186/s12929-017-0395-z.

16.

Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy.

Regla-Nava JA, Elong Ngono A, Viramontes KM, Huynh AT, Wang YT, Nguyen AT, Salgado R, Mamidi A, Kim K, Diamond MS, Shresta S.

Nat Commun. 2018 Aug 2;9(1):3042. doi: 10.1038/s41467-018-05458-0.

17.

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis.

Xie X, Yang Y, Muruato AE, Zou J, Shan C, Nunes BT, Medeiros DB, Vasconcelos PF, Weaver SC, Rossi SL, Shi PY.

MBio. 2017 Feb 7;8(1). pii: e02134-16. doi: 10.1128/mBio.02134-16.

18.

Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology.

Priyamvada L, Hudson W, Ahmed R, Wrammert J.

Emerg Microbes Infect. 2017 May 10;6(5):e33. doi: 10.1038/emi.2017.42. Review.

19.

Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.

Tsai WY, Youn HH, Brites C, Tsai JJ, Tyson J, Pedroso C, Drexler JF, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK.

Clin Infect Dis. 2017 Nov 13;65(11):1829-1836. doi: 10.1093/cid/cix672.

PMID:
29020159
20.

Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.

Rogers TF, Goodwin EC, Briney B, Sok D, Beutler N, Strubel A, Nedellec R, Le K, Brown ME, Burton DR, Walker LM.

Sci Immunol. 2017 Aug 18;2(14). pii: eaan6809. doi: 10.1126/sciimmunol.aan6809.

Supplemental Content

Support Center